1.) Kvasnickova, L., Glatz, Z., Sterbova, H., Kahle, V., Slanina, J., and Musil, P. Application of capillary electrochromatography using macroporous polyacrylamide columns for the analysis of lignans from seeds of Schisandra chinensis. J Chromatogr.A 5-4-2001;916(1-2):265-271.
2.) Upton R, ed. Schisandra Berry: Analytical, quality control, and therapeutic monograph. Santa Cruz, CA: American Herbal Pharmacopoeia 1999;1-25.
3.) Chiu, P. Y., Tang, M. H., Mak, D. H., Poon, M. K., and Ko, K. M. Hepatoprotective mechanism of schisandrin B: role of mitochondrial glutathione antioxidant status and heat shock proteins. Free Radic.Biol.Med 8-15-2003;35(4):368-380.
4.) Lee IS, Jung KY, Oh SR, et al. Structure-activity relationships of lignans from Schisandra chinensis as platelet activating antagonists. Biol Pharm Bull 1999;22:265-7.
5.) Bensky D, Gamble A. Chinese Herbal Medicine: Materia Medica, Revised Edition. Seattle, WA: Eastland Press; 1993. 6.) Hong YH. Oriental Materia Medica: A Concise Guide. Long Beach, CA: Oriental Healing Arts Institute; 1986. 7.) Lu H, Liu GT. Effect of dibenzo[a,c]cyclootene lignans isolated from fructus Schizandrae on lipid peroxidation and anti-oxidative enzyme activity. Chem Biol Interact 1991;78:77-84. 8.) Li XJ, Zhao BL, Liu GT, Xin WJ. Scavenging effects on active oxygen radicals by schizandrins with different structures and configurations. Free Radic Biol Med 1990;9:99-104. 9.) Li XY. Bioactivity of neolignans from fructus Schizandrae. Mem Inst Oswaldo Cruz 1991;86:31-37. 10.) Liu KT, Lesca P. Pharmacological properties of dibenzo[a,c]cycloctene derivatives isolated from Fructus Schizandrae chinsesisIII. Inhibitory effects on carbon tetrachloride induced lipid peroxidation, metabolism and covalent binding of CCl4 to lipids. Chem Biol Interact 1982;41:39-47. 11.) Liu GT. Pharmacological actions and clinical use of fructus Schizandrae. Chin Med J 1989;102:740-749.